EUVIMED · CrossrefZeitschrift
The AAPS Journal
ISSN 1550-7416 · Springer Science and Business Media LLC
Neueste Artikel
A Strategic Framework for Optimized Bioanalytical Outsourcing: An Integrated Approach to Assay Development, CRO Selection, and Performance Governance
Population Pharmacokinetic Model for 6-chromanol SUL-238 Across Rats and Minipigs, a Novel Drug Designed to Protect and Restore Mitochondrial Function
Advancing A Comprehensive Strategy for Immunogenicity Cut Point Evaluation
Formation of Nitrosamine Drug Substance-Related Impurities from Vulnerable Amine Impurities: Determination and Evaluation of Their Extents of Conversion in Solid Drug Products
Impact of Chronological Age, Proton Pump Inhibitors in Older Adults, and Diabetes in Older Adults on Physicochemical Characteristics of Antral Contents During Fasting: An Exploratory Study
Evaluating Immunogenicity Potential of Host Cell Proteins: Unveiling Novel Insights and Risks by LC–MS/MS MHC-Associated Peptide Profiling
Charcoal-Based Depletion Method to Improve Drug Tolerance in Neutralizing Antibody Assays for Therapeutic Peptides
Vancomycin Pharmacokinetics and Nephrotoxicity in Kidney Transplant Recipients: A Retrospective Cohort Study
Artificial Intelligence in Pharmaceutical Regulatory Science: Opportunities, Challenges, and Emerging Frameworks
Immunogenicity in Approved Adeno-Associated Virus-Based Gene Therapies: A Framework for a Tailored Assessment Strategy
Investigating the Impact of Food Induced Fluid Viscosity on Disintegration and Dissolution of Immediate Release Midodrine HCl Tablet
Calculating Receptor Occupancy using TMDD Models – What has to be Considered?
Updated Recommendations for the Bioanalysis of Antibody–Drug Conjugates (ADC) from the ADC working group of the AAPS Bioanalytical Community
In vivo Predictive Dissolution Test Using Biorelevant Bicarbonate Buffer for High-dose Free Acid Drug
Simple Hydrodynamic Molecular Weight Model for Rapid Assessment of Therapeutic Protein Oligomerization States in Formulation
Whole-Body Pharmacokinetics of Ionizable Lipid, mRNA, and the Expressed Antibody following Intravenous Administration of mRNA-Loaded Lipid Nanoparticles
Guiding the Molnupiravir Tablet Formulation Using Physiologically Based Biopharmaceutics Modeling and Successfully Establishing Dissolution Safe Space
Correction: Nanotechnology-enhanced Natural Products for Cancer Chemoprevention: Molecular Mechanisms and Clinical Translation
Quantitative Estimation of Clinical Intrasubject Variability of a Pharmacokinetic Parameter
Targeting Pyruvate Kinase M2: Signal Transduction Pathways and Exploration of Cancer Therapeutic Strategies
Context-of-use–Guided Development and Validation of a Transthyretin Immunoassay: A Framework for Biomarker Assay Design
New Frontiers of Drug Development Through the Use of New Approach Methodologies
Correction to: Considerations in Kp,uu,brain-based Strategy for Selecting CNS-targeted Drug Candidates with Sufficient Target Coverage and Substantial Pharmacodynamic Effect
Development and Implementation of a Hinderance-based In Vitro Model for Porous Membranes
A Mechanistic Framework Integrating Renal QSP-PK-PD and Machine Learning for Baseline-Informed Stratification of Diuretic Resistance
HLA Class II Alleles DRB1*11:01 and DQB1*03:01 Unmask Immunogenetic Susceptibility to Anti-Nivolumab Antibodies in Combination with Ipilimumab
Immunogenicity Assessment for siRNA Therapeutics: A Risk-Based Proposal for Event-Driven Testing
Applications of Thermoresponsive Hydrogels for Sustained Drug Release in Ocular and Intravitreal Formulations Treating Visual Impairments
Estimating Intragastric Disintegration Times of Immediate Release Dose Units Administered After a High-Calorie, High-Fat Meal Using Standardized, Commercially Available Equipment and Materials
High Concordance of Total Antibody and Transduction Inhibition Assays Enables Replacement of Cell-Based Antibody Testing for Preexisting Anti-AAV Immunity in Cynomolgus Monkey
EUVIMED